You are here:
Sanofi-Aventis
#Sanofi-Aventis
Get Alerts

Articles

View all

India Inc strikes deals worth nearly $27 bn in last 11 months

Dec 11, 2013

India Inc strikes deals worth nearly $27 bn in last 11 months

According to assurance, tax and advisory firm Grant Thornton, corporates in the country announced 458 deals in the January-November period amounting to USD 26.76 billion. #didyouknow #Sanofi-Aventis #Grant Thornton #Lodha Group #McDonald House
Shantha Biotech buyout: Sanofi to pay tax in France not India

Feb 16, 2013

Shantha Biotech buyout: Sanofi to pay tax in France not India

The Andhra Pradesh High Court today ruled that French drug maker Sanofi Aventis will not have to pay taxes in India for its buyout of Hyderabad-based vaccine firm Shantha Biotechnics in 2009. #NewsTracker #Sanofi-Aventis #Double taxation #Income tax #Shantha Biotech
Lupin gets USFDA approval for hypertension pills

Oct 17, 2012

Lupin gets USFDA approval for hypertension pills

Pharma major Lupin Wednesday said it has got approval from the US Food and Drugs Administration (FDA) to market generic versions of Sanofi Aventis' Avapro tablets, prescribed in the treatment of hypertension and nephropathy in Type-II diabetis. #Sanofi-Aventis #CompanyWatch #Lupin #Hypertension #USFDA
Dengue vaccine possible, though not any time soon

Sep 11, 2012

Dengue vaccine possible, though not any time soon

Inital trials of the dengue vaccine that were carried out in Thailand have been less than encouraging with only 30 percent efficacy and more research will be required. #NewsTracker #Sanofi-Aventis #Vaccine #Dengue fever #Thaliand
Cipla loses US court appeal over animal healthcare product

Jun 08, 2012

Cipla loses US court appeal over animal healthcare product

Pharmaceuticals major Cipla lost an appeal in the US court against Merial ltd, a subsidiary of Sanofi-Aventis for an animal healthcare product. Merial took Cipla to court saying the product infringed on a patent owned by Merial. #Health/Medical/Pharmaceuticals #Sanofi-Aventis S.A. #Cipla #CompanyWatch #Aventis #Cipla Ltd #Merial